Facebook
X
LinkedIn
ForwardCOVID-19 Considerations in High-risk Pediatric Populations
0.5 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: [email protected].
Copyright © 2026 by the National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. all rights reserved.
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an agency providing continuing education credit. individuals who complete this program and earn a 70% or higher score on the post test will be awarded 0.5 NAPNAP contact hour.
This presentation is supported by an independent medical education grant from Pfizer.
Target Audience
Pediatric-focused advanced practice registered nurses
Learning Objectives
After completing this continuing education course, the participant will be able to:
- Identify various unique populations that present in outpatient settings and are in need of access to COVID-19 prevention and prompt treatment.
- Follow a case of a high-risk patients as their health progresses across the care continuum, from primary care presentation to urgent care/emergency department to in-patient intensive care and through to outpatient follow up care.
- Prescribe appropriate treatment to prevent negative outcomes from COVID-19 illness in children with high-risk health conditions.
- Address unique health care access issues present today, including vaccine and treatment coverage, lack of vaccine availability, finding a vaccine source, and advocating for patients that require high-risk attention.
Additional Information
| Attachment | Size |
|---|---|
 COVID-19 High Risk Handout.pdf | 416.74 KB |
Meara Henley, DNP, RN, CPNP-PC, PMHS
Michael A. Maymi, DNP, CPNP-AC, CCRN
Faculty Disclosures
Meara Henley has no relevant financial disclosures.
Michael Maymi has no relevant financial disclosures.
This presentation is supported by an independent medical education grant from Pfizer.
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an agency providing continuing education credit. individuals who complete this program and earn a 70% or higher score on the post test will be awarded 0.5 NAPNAP contact hour.
Available Credit
- 0.50 Contact hours